MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,485 | +8.8% | 17,576 | 0.0% | 0.00% | – |
| Q2 2023 | $50,091 | -27.7% | 17,576 | 0.0% | 0.00% | – |
| Q1 2023 | $69,249 | +100260.9% | 17,576 | 0.0% | 0.00% | – |
| Q4 2022 | $69 | -100.0% | 17,576 | 0.0% | 0.00% | – |
| Q3 2022 | $161,000 | +54.8% | 17,576 | 0.0% | 0.00% | – |
| Q2 2022 | $104,000 | -7.1% | 17,576 | 0.0% | 0.00% | – |
| Q1 2022 | $112,000 | -2.6% | 17,576 | 0.0% | 0.00% | – |
| Q4 2021 | $115,000 | +15.0% | 17,576 | 0.0% | 0.00% | – |
| Q3 2021 | $100,000 | -12.3% | 17,576 | -15.7% | 0.00% | – |
| Q2 2021 | $114,000 | -5.0% | 20,859 | 0.0% | 0.00% | – |
| Q1 2021 | $120,000 | -4.8% | 20,859 | +10.1% | 0.00% | – |
| Q4 2020 | $126,000 | +35.5% | 18,945 | +48.1% | 0.00% | – |
| Q3 2020 | $93,000 | +93.8% | 12,795 | 0.0% | 0.00% | – |
| Q2 2020 | $48,000 | – | 12,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |